FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Healthcare & Life Sciences Enterprise Capital Monitor – USA – 03/2024”.
The Monitor is a month-to-month revealed overview of enterprise capital traits within the US Healthcare & Life Sciences sector.
As of the top of March 2024 we recognized the next present VC traits in the USA:
- Complete Healthcare & Life Sciences funding reached EUR 8,217m
- Biotech acquired 61% of the entire funding quantity (EUR 5,037m) with oncology being the main indication (31%)
- In March Mirador Therapeutics secures the best transaction quantity with EUR 368m, adopted by Alumis with EUR 240m and Avenzo with EUR 205m
- Premji Make investments (United States) is probably the most lively investor (by deal quantity), adopted by RA Capital Administration (United States) and Novo Holdings (Denmark)
To entry the total report, please click on right here.
By Mathias Klozenbücher und Johannes Hyperlink.